Paper35720474
Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study.
Yan J and 4 others. Oncol Lett, 2022. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study. Papers, record 35720474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720474
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31863815 | Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. | Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31863815 | PubMed |
| 2 | 28583134 | Sphingosine kinase 1 expression enhances colon tumor growth. | J Transl Med | 2017 | https://conductscience.org/library/papers/28583134 | PubMed |
| 3 | 23723450 | Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. | Blood | 2013 | https://conductscience.org/library/papers/23723450 | PubMed |
| 4 | 26937138 | Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26937138 | PubMed |
| 5 | 22098666 | Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. | Liver Int | 2012 | https://conductscience.org/library/papers/22098666 | PubMed |
| 6 | 27080739 | Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy. | Sci Rep | 2016 | https://conductscience.org/library/papers/27080739 | PubMed |
| 7 | 21527515 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. | Blood | 2011 | https://conductscience.org/library/papers/21527515 | PubMed |
| 8 | 26429117 | Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation. | Adv Biol Regul | 2016 | https://conductscience.org/library/papers/26429117 | PubMed |
| 9 | 18058224 | Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. | Breast Cancer Res Treat | 2008 | https://conductscience.org/library/papers/18058224 | PubMed |
| 10 | 19937366 | The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients. | J Neurooncol | 2010 | https://conductscience.org/library/papers/19937366 | PubMed |
| 11 | 31826690 | Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells. | Pediatr Hematol Oncol | 2020 | https://conductscience.org/library/papers/31826690 | PubMed |
| 12 | 27160553 | Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2. | Sci Rep | 2016 | https://conductscience.org/library/papers/27160553 | PubMed |
| 13 | 28075451 | The role of sphingolipid signalling in diabetes‑associated pathologies (Review). | Int J Mol Med | 2017 | https://conductscience.org/library/papers/28075451 | PubMed |
| 14 | 25084322 | Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues. | Exp Mol Pathol | 2014 | https://conductscience.org/library/papers/25084322 | PubMed |
| 15 | 20889557 | High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20889557 | PubMed |
| 16 | 12810709 | Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12810709 | PubMed |
| 17 | 26716409 | Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/26716409 | PubMed |
| 18 | 22500830 | S1PR2 links germinal center confinement and growth regulation. | Immunol Rev | 2012 | https://conductscience.org/library/papers/22500830 | PubMed |
| 19 | 23954895 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/23954895 | PubMed |
| 20 | 23273921 | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Cancer Cell | 2013 | https://conductscience.org/library/papers/23273921 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39328328 | Targeting SNAI1-Mediated Colorectal Cancer Chemoresistance and Stemness by Sphingosine Kinase 2 Inhibition. | World J Oncol | 2024 | https://conductscience.org/library/papers/39328328 | PubMed |
| 38473211 | Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473211 | PubMed |
| 36631680 | Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway. | Discov Oncol | 2023 | https://conductscience.org/library/papers/36631680 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35720474
GET https://conductscience.org/api/papers/v1/35720474/references?page=2